hepatocyte growth factor
| UniProt | Protein Name |
|---|---|
| P14210 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| mitotic cell cycle | ||
| cell morphogenesis | ||
| epithelial to mesenchymal transition | ||
| liver development | ||
| proteolysis |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular space | ||
| membrane | ||
| platelet alpha granule lumen |
| GO Term | Evidence Code | PMID |
|---|---|---|
| endopeptidase activity | ||
| serine-type endopeptidase activity | ||
| signaling receptor binding | ||
| protein binding | ||
| growth factor activity |
| Gene Ontology |
|---|
| proteolysis |
| serine-type endopeptidase activity |
| signaling receptor binding |
| InterPro |
|---|
| Kringle superfamily |
| Kringle, conserved site |
| Kringle-like fold |
| Kringle |
| PAN/Apple domain |
| Serine proteases, trypsin domain |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050852 | limb ischemia | |
| DOID:0081267 | graft-versus-host disease | |
| DOID:0110497 | autosomal recessive nonsyndromic deafness 39 | |
| DOID:10126 | keratoconus | |
| DOID:10763 | hypertension | |
| DOID:11446 | sciatic neuropathy | |
| DOID:11830 | myopia | |
| DOID:12306 | vitiligo | |
| DOID:13550 | angle-closure glaucoma | |
| DOID:2741 | bilirubin metabolic disorder |
| Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
|---|---|---|---|
| 3082 | Xenbase:XB-GENE-999992 | ||
| 15234 | Xenbase:XB-GENE-999992 | MOUSE44721 | |
| 24446 | Xenbase:XB-GENE-999992 | RATNO30163 | |
| 282879 | BOVIN27851 | ||
| 403441 | CANLF05577 | ||
| 443075 | SHEEP15394 | ||
| 463503 | PANTR40638 | ||
| 493705 | FELCA05333 | ||
| 493781 | DANRE32694 | ||
| 708316 | MACMU32274 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025